Skip to search.
New User?
Register
Sign In
Help
Make Y! My Homepage
Notifications
Help
Mail
My Y!
Yahoo!
Yahoo! UK & Ireland Finance
Search
Search Web
Home
Currency Converter
Video
Fantasy Share Trading
From The Newsroom
Financial Glossary
UK Budget 2013
How Money Works
Pension Changes
Investing
Market Movers
Indices
Currency Investor
Fantasy Trader
News & Opinion
Earnings
All Topics
Small Caps
Economy
Market Movers
Upgrades & Downgrades
Newspaper Tips
RSS Feeds
UK Budget 2013
My Portfolios
Sign in to access My Portfolios
Personal Finance
Loans
Credit Cards
Insurance
Savings
Mortgages
Pensions
Bank Accounts
Money Guides
Compare Products
Property
Real Money
Search for share prices
Search for share prices
Wed 22 May 2013 10:28 - UK Markets close in 6 hrs 2 mins
FTSE 100
0.26%
More On AZN.L
Quotes
Summary
Order Book
Options
Historical Prices
Derivatives
Warrants
Investment Products
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Company Events
Message Boards
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
AstraZeneca PLC (AZN.L)
-
LSE
3,418.50
24.00
(0.71%)
10:12
Add to Portfolio
Headlines
Get Headlines for:
Monday, 20 May 2013
AstraZeneca closes in on site for new home in Cambridge
Reuters - UK Focus
(Mon 20 May)
Thursday, 16 May 2013
AstraZeneca accelerates cancer drug testing
Reuters - UK Focus
(Thu 16 May)
Wednesday, 15 May 2013
Cubist bid for Optimer before sale process began-sources
Reuters - UK Focus
(Wed 15 May)
Dish lines up banks to finance Sprint bid -sources
Reuters - UK Focus
(Wed 15 May)
Dish lines up banks to finance Sprint bid -sources
Reuters - UK Focus
(Wed 15 May)
Cubist bid almost $1 bln for Optimer before sale process-sources
Reuters - UK Focus
(Wed 15 May)
Tuesday, 14 May 2013
A taste for defensives sours prospects for European stocks
Reuters - UK Focus
(Tue 14 May)
Friday, 10 May 2013
US FDA approves Glaxo/Theravance drug for COPD lung disease
Reuters - UK Focus
(Fri 10 May)
Thursday, 9 May 2013
U.S. spending on medicines fell for first time in 2012
Reuters - UK Focus
(Thu 9 May)
Tuesday, 30 April 2013
Veeva Systems planning initial public offering - sources
Reuters - UK Focus
(Tue 30 Apr)
Thursday, 25 April 2013
UPDATE 2-AstraZeneca hit by generic drugs and Crestor shortfall
Reuters - UK Focus
(Thu 25 Apr)
AstraZeneca gets U.S. subpoena over UK drug factory
Reuters - UK Focus
(Thu 25 Apr)
AstraZeneca profits fall 36pc in first quarter
Telegraph
(Thu 25 Apr)
AstraZeneca Q1 sales tumble as generic losses bite deep
Reuters - UK Focus
(Thu 25 Apr)
Tuesday, 23 April 2013
Moody's sees pick-up in pharmaceutical industry M&A in 2013
Reuters - UK Focus
(Tue 23 Apr)
Monday, 22 April 2013
AstraZeneca unites with biotech firm to forge new cancer treatment
Telegraph
(Mon 22 Apr)
AstraZeneca bets on nanotech with Bind Therapeutics deal
Reuters - UK Focus
(Mon 22 Apr)
Older Headlines
View headlines from:
Monday, 22 April 2013
Monday, 15 April 2013
Monday, 8 April 2013
Monday, 1 April 2013
Monday, 25 March 2013
Monday, 18 March 2013
Monday, 11 March 2013
Monday, 4 March 2013
Monday, 25 February 2013
Monday, 18 February 2013
1186050158